AAA
Affinity Asset Advisors Portfolio holdings
AUM
$676M
This Quarter Return
+11.4%
1 Year Return
+29.75%
3 Year Return
+452.89%
5 Year Return
–
10 Year Return
–
AUM
$254M
AUM Growth
+$254M
(-2.4%)
Cap. Flow
-$24.8M
Cap. Flow
% of AUM
-9.74%
Top 10 Holdings %
Top 10 Hldgs %
51.68%
Holding
90
New
19
Increased
14
Reduced
15
Closed
19
Top Buys
| 1 |
Teva Pharmaceuticals
TEVA
|
$12M |
| 2 |
Biogen
BIIB
|
$11.4M |
| 3 |
Prothena Corp
PRTA
|
$6.83M |
| 4 |
Establishment Labs
ESTA
|
$6.75M |
| 5 |
Kura Oncology
KURA
|
$5.85M |
Top Sells
| 1 |
KDNY
Chinook Therapeutics, Inc. Common Stock
KDNY
|
$25.2M |
| 2 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$16.1M |
| 3 |
Merck
MRK
|
$12.8M |
| 4 |
BLU
BELLUS Health Inc.
BLU
|
$6.35M |
| 5 |
Ventyx Biosciences
VTYX
|
$5.23M |
Sector Composition
| 1 | Healthcare | 94.05% |
